期刊
RADIOTHERAPY AND ONCOLOGY
卷 99, 期 3, 页码 373-378出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2011.05.086
关键词
Cancer stem cells; Radiation resistance; Nicotinamide; NNMT
资金
- Danish Cancer Society
- Danish Medical Research Council
- Danish Council for Strategic Research
- CIRRO - The Lundbeck Foundation Centre for Interventional Research in Radiation Oncology
- The A.P. Moller Foundation for the Advancement of Medical Science
Background: Cancer stem cells are thought to be a radioresistant population and may be the seeds for recurrence after radiotherapy. Using tumorigenic clones of retroviral immortalized human mesenchymal stem cell with small differences in their phenotype, we investigated possible genetic expression that could explain cancer stem cell radiation resistance. Methods: Tumorigenic mesenchymal cancer stem cell clones BB3 and CE8 were irradiated at varying doses and assayed for clonogenic surviving fraction. Altered gene expression before and after 2 Gy was assessed by Affymetric exon chip analysis and further validated with q-RT-PCR using TaqMan probes. Results: The CE8 clone was more radiation resistant than the BB3 clone. From a pool of 15 validated genes with altered expression in the CE8 clone, we found the enzyme nicotinamide N-methyltransferase (NNMT) more than 5-fold upregulated. In-depth pathway analysis found the genes involved in cancer, proliferation, DNA repair and cell death. Conclusions: The higher radiation resistance in clone CE8 is likely due to NNMT overexpression. The higher levels of NNMT could affect the cellular damage resistance through depletion of the accessible amounts of nicotinamide, which is a known inhibitor of cellular DNA repair mechanisms. (C) 2011 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 99 (2011) 373-378
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据